Amphastar Pharmaceuticals, Inc. (AMPH) Stock Profile — Insider Trades & Financials

Revenue$183.1M

Net Income$24.4M

EPS$2.03

Gross Margin46.8%

Market Cap$934.6M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Mary Z. Luo

CEO & Executive Director

Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.

Employees: 1,615
Headquarters: RANCHO CUCAMONGA, CA, United States
Website: www.amphastar.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

3.10%

ROA?

1.50%

D/E Ratio?

1.07

Op. Margin?

19.45%

📊

Profitability Ratios

Net Margin?

13.34%

Loading company sections...

Amphastar Pharmaceuticals, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness